Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. 1997

A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Limited, CH-4002 Basel, Switzerland.

Protease nexin-1 (PN-1), a member of the serpin superfamily, controls the activity of extracellular serine proteases and is expressed in the brain. Mutant mice overexpressing PN-1 in brain under the control of the Thy-1 promoter (Thy 1/PN-1) or lacking PN-1 (PN-1-/-) were found to develop epileptic activity in vivo and in vitro. Theta burst-induced long-term potentiation (LTP) and NMDA receptor-mediated synaptic transmission in the CA1 field of hippocampal slices were augmented in Thy 1/PN-1 mice and reduced in PN-1-/- mice. Compensatory changes in GABA-mediated inhibition in Thy 1/PN-1 mice suggest that altered brain PN-1 levels lead to an imbalance between excitatory and inhibitory synaptic transmission.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008818 Mice, Neurologic Mutants Mice which carry mutant genes for neurologic defects or abnormalities. Lurcher Mice,Nervous Mice,Reeler Mice,Staggerer Mice,Weaver Mice,Chakragati Mice,Chakragati Mouse,Lurcher Mouse,Mice, Neurological Mutants,Mouse, Neurologic Mutant,Mouse, Neurological Mutant,Nervous Mouse,Neurologic Mutant Mice,Neurological Mutant Mouse,Reeler Mouse,Staggerer Mouse,Weaver Mouse,ckr Mutant Mice,Mice, Chakragati,Mice, Lurcher,Mice, Nervous,Mice, Neurologic Mutant,Mice, Reeler,Mice, Staggerer,Mice, Weaver,Mice, ckr Mutant,Mouse, Chakragati,Mouse, Lurcher,Mouse, Nervous,Mouse, Reeler,Mouse, Staggerer,Mouse, Weaver,Mutant Mice, Neurologic,Mutant Mice, ckr,Mutant Mouse, Neurologic,Neurologic Mutant Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders

Related Publications

A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
August 1997, Nature,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
September 1994, Neuroscience,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
May 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
September 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
November 2017, Physiological reports,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
February 2015, Journal of neural transmission (Vienna, Austria : 1996),
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
September 2021, The Journal of neuroscience : the official journal of the Society for Neuroscience,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
December 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
March 2009, Naunyn-Schmiedeberg's archives of pharmacology,
A Lüthi, and H Van der Putten, and F M Botteri, and I M Mansuy, and M Meins, and U Frey, and G Sansig, and C Portet, and M Schmutz, and M Schröder, and C Nitsch, and J P Laurent, and D Monard
December 2003, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!